106 related articles for article (PubMed ID: 21757343)
21. Design, synthesis, and structure-activity relationships of novel bicyclic azole-amines as negative allosteric modulators of metabotropic glutamate receptor 5.
Burdi DF; Hunt R; Fan L; Hu T; Wang J; Guo Z; Huang Z; Wu C; Hardy L; Detheux M; Orsini MA; Quinton MS; Lew R; Spear K
J Med Chem; 2010 Oct; 53(19):7107-18. PubMed ID: 20809633
[TBL] [Abstract][Full Text] [Related]
22. 2-Amino-5-aryl-pyridines as selective CB2 agonists: synthesis and investigation of structure-activity relationships.
Gleave RJ; Beswick PJ; Brown AJ; Giblin GM; Haslam CP; Livermore D; Moses A; Nicholson NH; Page LW; Slingsby B; Swarbrick ME
Bioorg Med Chem Lett; 2009 Dec; 19(23):6578-81. PubMed ID: 19864133
[TBL] [Abstract][Full Text] [Related]
23. 5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity.
Roppe JR; Wang B; Huang D; Tehrani L; Kamenecka T; Schweiger EJ; Anderson JJ; Brodkin J; Jiang X; Cramer M; Chung J; Reyes-Manalo G; Munoz B; Cosford ND
Bioorg Med Chem Lett; 2004 Aug; 14(15):3993-6. PubMed ID: 15225713
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and pharmacological characterization of novel druglike corticotropin-releasing factor 1 antagonists.
Di Fabio R; St-Denis Y; Sabbatini FM; Andreotti D; Arban R; Bernasconi G; Braggio S; Blaney FE; Capelli AM; Castiglioni E; Di Modugno E; Donati D; Fazzolari E; Ratti E; Feriani A; Contini S; Gentile G; Ghirlanda D; Provera S; Marchioro C; Roberts KL; Mingardi A; Mattioli M; Nalin A; Pavone F; Spada S; Trist DG; Worby A
J Med Chem; 2008 Dec; 51(23):7370-9. PubMed ID: 18989952
[TBL] [Abstract][Full Text] [Related]
25. 3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists.
Tehrani LR; Smith ND; Huang D; Poon SF; Roppe JR; Seiders TJ; Chapman DF; Chung J; Cramer M; Cosford ND
Bioorg Med Chem Lett; 2005 Nov; 15(22):5061-4. PubMed ID: 16183275
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and SAR of 2-aryl pyrido[2,3-d]pyrimidines as potent mGlu5 receptor antagonists.
Wendt JA; Deeter SD; Bove SE; Knauer CS; Brooker RM; Augelli-Szafran CE; Schwarz RD; Kinsora JJ; Kilgore KS
Bioorg Med Chem Lett; 2007 Oct; 17(19):5396-9. PubMed ID: 17723296
[TBL] [Abstract][Full Text] [Related]
27. (S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors.
Cosford ND; Bleicher L; Herbaut A; McCallum JS; Vernier JM; Dawson H; Whitten JP; Adams P; Chavez-Noriega L; Correa LD; Crona JH; Mahaffy LS; Menzaghi F; Rao TS; Reid R; Sacaan AI; Santori E; Stauderman KA; Whelan K; Lloyd GK; McDonald IA
J Med Chem; 1996 Aug; 39(17):3235-7. PubMed ID: 8765504
[No Abstract] [Full Text] [Related]
28. Structure-activity relationships for the linker in a series of pyridinyl-alkynes that are antagonists of the metabotropic glutamate receptor 5 (mGluR5).
Bach P; Nilsson K; Svensson T; Bauer U; Hammerland LG; Peterson A; Wållberg A; Osterlund K; Karis D; Boije M; Wensbo D
Bioorg Med Chem Lett; 2006 Sep; 16(18):4788-91. PubMed ID: 16837196
[TBL] [Abstract][Full Text] [Related]
29. mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy.
Löscher W; Dekundy A; Nagel J; Danysz W; Parsons CG; Potschka H
Neuropharmacology; 2006 Jun; 50(8):1006-15. PubMed ID: 16563443
[TBL] [Abstract][Full Text] [Related]
30. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.
Johnson MP; Nisenbaum ES; Large TH; Emkey R; Baez M; Kingston AE
Biochem Soc Trans; 2004 Nov; 32(Pt 5):881-7. PubMed ID: 15494040
[TBL] [Abstract][Full Text] [Related]
31. Arylmethoxypyridines as novel, potent and orally active mGlu5 receptor antagonists.
Büttelmann B; Peters JU; Ceccarelli S; Kolczewski S; Vieira E; Prinssen EP; Spooren W; Schuler F; Huwyler J; Porter RH; Jaeschke G
Bioorg Med Chem Lett; 2006 Apr; 16(7):1892-7. PubMed ID: 16439120
[TBL] [Abstract][Full Text] [Related]
32. 2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors.
Yan L; Budhu R; Huo P; Lynch CL; Hale JJ; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Mandala SM
Bioorg Med Chem Lett; 2006 Jul; 16(13):3564-8. PubMed ID: 16621543
[TBL] [Abstract][Full Text] [Related]
33. Azetidinyl oxadiazoles as potent mGluR5 positive allosteric modulators.
Packiarajan M; Ferreira CG; Hong SP; White AD; Chandrasena G; Pu X; Brodbeck RM; Robichaud AJ
Bioorg Med Chem Lett; 2012 Oct; 22(20):6469-74. PubMed ID: 22975301
[TBL] [Abstract][Full Text] [Related]
34. Discovery of novel positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).
Varnes JG; Marcus AP; Mauger RC; Throner SR; Hoesch V; King MM; Wang X; Sygowski LA; Spear N; Gadient R; Brown DG; Campbell JB
Bioorg Med Chem Lett; 2011 Mar; 21(5):1402-6. PubMed ID: 21295468
[TBL] [Abstract][Full Text] [Related]
35. Novel heterocyclic compounds as mGlu5 antagonists: WO2009015897.
Doller D; Li G; Brodbeck RM; Thomsen C
Expert Opin Ther Pat; 2010 Mar; 20(3):435-9. PubMed ID: 20180623
[TBL] [Abstract][Full Text] [Related]
36. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities.
Liu F; Grauer S; Kelley C; Navarra R; Graf R; Zhang G; Atkinson PJ; Popiolek M; Wantuch C; Khawaja X; Smith D; Olsen M; Kouranova E; Lai M; Pruthi F; Pulicicchio C; Day M; Gilbert A; Pausch MH; Brandon NJ; Beyer CE; Comery TA; Logue S; Rosenzweig-Lipson S; Marquis KL
J Pharmacol Exp Ther; 2008 Dec; 327(3):827-39. PubMed ID: 18753411
[TBL] [Abstract][Full Text] [Related]
37. 4-aryl piperazine and piperidine amides as novel mGluR5 positive allosteric modulators.
Xiong H; Brugel TA; Balestra M; Brown DG; Brush KA; Hightower C; Hinkley L; Hoesch V; Kang J; Koether GM; McCauley JP; McLaren FM; Panko LM; Simpson TR; Smith RW; Woods JM; Brockel B; Chhajlani V; Gadient RA; Spear N; Sygowski LA; Zhang M; Arora J; Breysse N; Wilson JM; Isaac M; Slassi A; King MM
Bioorg Med Chem Lett; 2010 Dec; 20(24):7381-4. PubMed ID: 21067920
[TBL] [Abstract][Full Text] [Related]
38. Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 2: 4-thiopyridyl acetophenones as non-tetrazole containing mGlu2 receptor potentiators.
Pinkerton AB; Cube RV; Hutchinson JH; James JK; Gardner MF; Schaffhauser H; Rowe BA; Daggett LP; Vernier JM
Bioorg Med Chem Lett; 2004 Dec; 14(23):5867-72. PubMed ID: 15501058
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of a new class of selective integrin alpha5beta1 antagonists.
Stragies R; Osterkamp F; Zischinsky G; Vossmeyer D; Kalkhof H; Reimer U; Zahn G
J Med Chem; 2007 Aug; 50(16):3786-94. PubMed ID: 17616113
[TBL] [Abstract][Full Text] [Related]
40. Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activity.
Smith ND; Poon SF; Huang D; Green M; King C; Tehrani L; Roppe JR; Chung J; Chapman DP; Cramer M; Cosford ND
Bioorg Med Chem Lett; 2004 Nov; 14(22):5481-4. PubMed ID: 15482908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
